Literature DB >> 22579030

Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo.

Doris D Wang1, Dario J Englot, Paul A Garcia, Michael T Lawton, William L Young.   

Abstract

INTRODUCTION: Increasing evidence suggests the role of inflammation in enhancing neuronal excitability and contributing to epileptogenesis. Tetracycline-class antibiotics minocycline, doxycycline and tetracycline have been shown to have anti-apoptotic and anti-inflammatory effects.
METHODS: We investigated the anti-seizure effects of tetracycline-class antibiotics minocycline, doxycycline and tetracycline in vivo by using the maximal electric shock (MES), 6-Hz (minimal clonic seizure) test and subcutaneous Metrazol (scMET) models of epilepsy.
RESULTS: Minocycline, doxycycline and tetracycline showed anticonvulsant effects in abolishing partial seizures in the mouse 6-Hz seizure test. A dose-dependent effect was found, with ED(50) of 170 mg/kg for minocycline, 157 mg/kg for doxycycline, and 255 mg/kg for tetracycline with peak onset at 0.5h. At high doses, minocycline (250 mg/kg) and doxycycline (150 mg/kg) also had toxic effects, from motor impairments to respiratory failure and death. These drugs had no effects on the MES and scMET tests.
CONCLUSIONS: In the three tests of anti-seizure activity, minocycline, doxycycline, and tetracycline were found to be protective in one: the 6-Hz seizure model. Our data suggest that minocycline and other tetracycline-class drugs may offer some degree of anticonvulsant effect in the setting of CNS disease trials. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579030      PMCID: PMC3761078          DOI: 10.1016/j.yebeh.2012.03.035

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  27 in total

1.  Studies on the mechanism of amphetamine toxicity in aggregated mice.

Authors:  E A SWINYARD; L D CLARK; J T MIYAHARA; H H WOLF
Journal:  J Pharmacol Exp Ther       Date:  1961-04       Impact factor: 4.030

2.  Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test.

Authors:  W C BROWN; D O SCHIFFMAN; E A SWINYARD; L S GOODMAN
Journal:  J Pharmacol Exp Ther       Date:  1953-03       Impact factor: 4.030

3.  Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro.

Authors:  Midori A Yenari; Lijun Xu; Xian Nan Tang; Yanli Qiao; Rona G Giffard
Journal:  Stroke       Date:  2006-02-23       Impact factor: 7.914

4.  The search for new drugs against epilepsy.

Authors:  J E P TOMAN; G M EVERETT; R K RICHARDS
Journal:  Tex Rep Biol Med       Date:  1952

5.  Doxycycline protects against pilocarpine-induced convulsions in rats, through its antioxidant effect and modulation of brain amino acids.

Authors:  Carlos Renato Alves Nogueira; Flávio Maia Damasceno; Manuel Rufino de Aquino-Neto; Geanne Matos de Andrade; Juvênia Bezerra Fontenele; Thales Augusto de Medeiros; Glauce Socorro de Barros Viana
Journal:  Pharmacol Biochem Behav       Date:  2011-03-05       Impact factor: 3.533

6.  A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.

Authors: 
Journal:  Neurology       Date:  2006-02-15       Impact factor: 9.910

7.  A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

Authors: 
Journal:  Clin Neuropharmacol       Date:  2008 May-Jun       Impact factor: 1.592

Review 8.  Minocycline and neurodegenerative diseases.

Authors:  Hye-Sun Kim; Yoo-Hun Suh
Journal:  Behav Brain Res       Date:  2008-10-11       Impact factor: 3.332

9.  Inflammation is detrimental for neurogenesis in adult brain.

Authors:  Christine T Ekdahl; Jan-Hendrik Claasen; Sara Bonde; Zaal Kokaia; Olle Lindvall
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

10.  Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.

Authors:  Livia S Machado; Anna Kozak; Adviye Ergul; David C Hess; Cesario V Borlongan; Susan C Fagan
Journal:  BMC Neurosci       Date:  2006-07-17       Impact factor: 3.288

View more
  25 in total

1.  Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.

Authors:  Dai-Shi Tian; Jiyun Peng; Madhuvika Murugan; Li-Jie Feng; Jun-Li Liu; Ukpong B Eyo; Li-Jun Zhou; Rochelle Mogilevsky; Wei Wang; Long-Jun Wu
Journal:  J Neurosci       Date:  2017-07-17       Impact factor: 6.167

2.  Effect of minocycline on pentylenetetrazol-induced chemical kindled seizures in mice.

Authors:  Nooshin Ahmadirad; Amir Shojaei; Mohammad Javan; Mohammad H Pourgholami; Javad Mirnajafi-Zadeh
Journal:  Neurol Sci       Date:  2013-10-15       Impact factor: 3.307

Review 3.  The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.

Authors:  Donald C Rojas
Journal:  J Neural Transm (Vienna)       Date:  2014-04-22       Impact factor: 3.575

4.  Repurposing Tigecycline for the Treatment of Alcohol Use Disorder.

Authors:  Alfredo Oliveros; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2017-01-30       Impact factor: 3.455

5.  Neurological and Psychiatric Adverse Effects of Antimicrobials.

Authors:  Madison K Bangert; Rodrigo Hasbun
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

6.  Effective Reduction of Acute Ethanol Withdrawal by the Tetracycline Derivative, Tigecycline, in Female and Male DBA/2J Mice.

Authors:  Joseph M Martinez; Jessica A Groot; David C Curtis; Clayton L Allison; Patrick C Marquardt; Ashley N Holmes; David S Edwards; David R M Trotter; Peter J Syapin; Deborah A Finn; Susan E Bergeson
Journal:  Alcohol Clin Exp Res       Date:  2016-11-14       Impact factor: 3.455

Review 7.  Tumor necrosis factor-α modulates cerebral aneurysm formation and rupture.

Authors:  Robert M Starke; Daniel M S Raper; Dale Ding; Nohra Chalouhi; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-09-20       Impact factor: 6.829

Review 8.  Microglia-Neuron Communication in Epilepsy.

Authors:  Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Glia       Date:  2016-05-18       Impact factor: 7.452

9.  Myoloid-related protein 8, an endogenous ligand of Toll-like receptor 4, is involved in epileptogenesis of mesial temporal lobe epilepsy via activation of the nuclear factor-κB pathway in astrocytes.

Authors:  Na Gan; Lifen Yang; Ahmed Omran; Jing Peng; Liwen Wu; Fang He; Ciliu Zhang; Qiulian Xiang; Huimin Kong; Yupin Ma; Muhammad Usman Ashhab; Xiaolu Deng; Fei Yin
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

Review 10.  Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation.

Authors:  Raimondo D'Ambrosio; Clifford L Eastman; Cinzia Fattore; Emilio Perucca
Journal:  Expert Rev Neurother       Date:  2013-06       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.